Regulation Catches Up to Reality: Nonadjunctive Use of Continuous Glucose Monitoring Data

par Edelman, Steven V.
Publié dans J Diabetes Sci Technol (2016)

Taking Control Of Your Diabetes: An Innovative Approach to Improving Diabetes Care Through Educating, Motivating, and Making the Connection Between Patients and Health Care Provide...

par Edelman, Steven V.
Publié dans Clin Diabetes (2017)

Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring

par Pettus, Jeremy, Edelman, Steven V.
Publié dans Diabetes Technol Ther (2016)

Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM)

par Pettus, Jeremy, Edelman, Steven V.
Publié dans J Diabetes Sci Technol (2016)

Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 Diabetes

par Pettus, Jeremy, Edelman, Steven V.
Publié dans J Diabetes Sci Technol (2016)

Sodium‐glucose co‐transporter inhibitors as adjunctive treatment to insulin in type 1 diabetes: A review of randomized controlled trials

par Boeder, Schafer, Edelman, Steven V.
Publié dans Diabetes Obes Metab (2019)

Practical Strategies to Help Reduce Added Sugars Consumption to Support Glycemic and Weight Management Goals

par Warshaw, Hope, Edelman, Steven V.
Publié dans Clin Diabetes (2021)

United States Patient Preference and Usability for the New Disposable Insulin Device Solostar(®) versus Other Disposable Pens

par Fischer, Jerome S., Edelman, Steven V., Schwartz, Sherwyn L.
Publié 2008

Gastrointestinal Complications of Diabetes

par Boland, Brigid S., Edelman, Steven V., Wolosin, James D.
Publié dans Endocrinol Metab Clin North Am (2013)

Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy.

par Baron, A D, Laakso, M, Brechtel, G, Edelman, S V
Publié 1991

Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance.

par Laakso, M, Edelman, S V, Brechtel, G, Baron, A D
Publié 1990

Patients With Type 2 Diabetes Are Willing to Do More to Overcome Therapeutic Inertia: Results From a Double-Blind Survey

par Edelman, Steven V., Wood, Richard, Roberts, Michelle, Shubrook, Jay H.
Publié dans Clin Diabetes (2020)

Achievement of Glycated Hemoglobin Goals in the US Remains Unchanged Through 2014

par Carls, Ginger, Huynh, Johnny, Tuttle, Edward, Yee, John, Edelman, Steven V.
Publié dans Diabetes Ther (2017)

A 16-Week Open-Label, Multicenter Pilot Study Assessing Insulin Pump Therapy in Patients with Type 2 Diabetes Suboptimally Controlled with Multiple Daily Injections

par Frias, Juan P, Bode, Bruce W, Bailey, Timothy S, Kipnes, Mark S, Brunelle, Rocco, Edelman, Steven V
Publié 2011

Real‐world weight change among patients treated with glucagon‐like peptide‐1 receptor agonist, dipeptidyl peptidase‐4 inhibitor and sulfonylureas for type 2 diabetes and the influe...

par Carls, G. S., Tan, R., Zhu, J. Y., Tuttle, E., Yee, J., Edelman, S. V., Polonsky, W. H.
Publié dans Obes Sci Pract (2017)

Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©

par Jacobson, Terry A., Edelman, Steven V., Galipeau, Nina, Shields, Alan L., Mallya, Usha G., Koren, Andrew, Davidson, Michael H.
Publié dans Patient (2016)

Significant Insulin Dose Errors May Occur if Blood Glucose Results Are Obtained from Miscoded Meters

par Raine, Charles H., Schrock, Linda E., Edelman, Steven V., Mudaliar, Sunder Raj D., Zhong, Weiping, Proud, Lois J., Parkes, Joan Lee
Publié 2007

Ethnic Differences in Complementary and Alternative Medicine Use among Patients with Diabetes

par Villa-Caballero, Leonel, Morello, Candis M, Chynoweth, Megan E, Prieto-Rosinol, Ariadna, Polonsky, William H, Palinkas, Lawrence A, Edelman, Steven V
Publié 2010

Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: A real‐world study of more than 30 000 patients in a US electronic health record da...

par Pettus, Jeremy H., Zhou, Fang Liz, Shepherd, Leah, Mercaldi, Katie, Preblick, Ronald, Hunt, Phillip R., Paranjape, Sachin, Miller, Kellee M., Edelman, Steven V.
Publié dans Diabetes Obes Metab (2019)

Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus

par Ilag, L. L., Deeg, M. A., Costigan, T., Hollander, P., Blevins, T. C., Edelman, S. V., Konrad, R. J., Ortmann, R. A., Pollom, R. K., Huster, W. J., Zielonka, J. S., Prince, M. J.
Publié dans Diabetes Obes Metab (2016)